The global eClinical solutions market is projected to grow from USD 13.75 billion in 2024 to nearly USD 35.76 billion by 2032, registering a CAGR of 12.69%. Growth is driven by increasing adoption of AI-powered platforms, cloud-based clinical trial systems, and the shift toward decentralized and patient-centric trial models.
read more..